Content
77%Reviews the quality of instructions and guidance provided to agents. Good implementation is clear, handles edge cases, and produces reliable results.
The body is well-structured with concrete executable commands, a clear sequenced workflow, and a signaled reference file. Its main weaknesses are redundancy, padded meta-content, and a heavy monolithic SKILL.md that could offload more to references.
Suggestions
De-duplicate the compile/help commands (present in both Quick Check and Audit-Ready Commands) and consolidate Example Usage with the Example section.
Move meta-content such as Risk Assessment, Security Checklist, Evaluation Criteria, and Lifecycle Status into references/ to slim SKILL.md toward an overview.
Remove or refresh the stale 'Next Review Date: 2026-03-20' so time-sensitive metadata does not read as current guidance.
| Dimension | Reasoning | Score |
|---|---|---|
Conciseness | The body is mostly efficient but includes redundancy (py_compile appears in both Quick Check and Audit-Ready Commands; Example Usage overlaps Example) and padded meta-content, plus a stale 'Next Review Date: 2026-03-20'. | 2 / 3 |
Actionability | Provides concrete, copy-paste-ready commands (python -m py_compile scripts/main.py, python scripts/main.py --help, --stage series-a --audience biotech-specialist) and a specific parameters table, matching the 'fully executable commands; copy-paste ready' anchor. | 3 / 3 |
Workflow Clarity | The Workflow section gives five sequenced steps with an explicit checkpoint ('If scientific support or market context is missing, stop and request the minimum additional inputs') plus checklists, matching the 'clear sequence with explicit validation steps' anchor. | 3 / 3 |
Progressive Disclosure | The reference (references/audit-reference.md) is one level deep and clearly signaled, but SKILL.md carries substantial inline meta-content (Risk Assessment, Security Checklist, Evaluation Criteria, Lifecycle Status) that could be split out, and audit commands are duplicated across the two files. | 2 / 3 |
Total | 10 / 12 Passed |